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INTRODUCTION:  So  called  “extreme  oncoplastic  surgery”  is  emerging  as  a  new  promising  concept  in breast
cancer  surgery  allowing  successful  breast  conservation  in selected  patients  with  multicentric  tumors.
PRESENTATION  OF  CASE:  We  report  the  case  of  a 48-year-old  woman  presenting  with  a multicentric  breast
cancer  and  successfully  treated  with  an  oncoplastic  technique  consisting  in three  radical  lumpectomies
followed  by breast  reshaping  and  simultaneous  contralateral  symmetrization.





option  than  the  combination  of mastectomy,  reconstruction  and  radiation  therapy,  in  terms  of  quality  of
life for  selected  patients  affected  by multicentric  breast  cancer.
CONCLUSION:  The  surgical  treatment  for  multicentric  breast  cancers  remains  controversial  even  though
emerging  evidences  show  good  oncological  and aesthetic  outcomes  following  oncoplastic  conserving
breast  surgery.
©  2016  The  Authors.  Published  by Elsevier  Ltd  on  behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Tumor excision achieving free margins represented the only
oal for breast surgeons for many years. Nowadays Breast Conserv-
ng Surgery (BCS) represents the gold standard for early stage breast
ancer surgical treatment allowing the same long term survival
ates as for patients treated with radical mastectomy [1,2].
The modern approach of Oncoplastic Breast Surgery (OPBS)
ombines the oncological radicality of BCS with the optimal aes-
hetic result.
The breast reshaping after wide excision is followed by con-
ralateral breast symmetrization in order to reach a pleasant ﬁnal
esthetic result in a one-stage procedure.
Many oncoplastic approaches have been proposed during the
ast decades but few cases have been described for multifocal or
ulticentric cancers [3–9].
So called “extreme oncoplastic surgery” is emerging as a newromising concept in breast cancer surgery.
It allows successful breast conservation in selected patients with
ulticentric tumors.
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According to some authors’ experience, it could represent a bet-
ter option than the combination of mastectomy, reconstruction and
radiation therapy, from a quality of life point of view [10].
Moreover we must consider that a good cosmetic result follow-
ing breast conservation allows the patient to live her life with a
normal breast with almost completely preserved sensitivity.
We  present an extreme application of oncoplastic breast surgery
in a case of multicentric breast cancer, in accordance with the
SCARE Statement criteria [11].
2. Case report
In January 2015 a 48-year-old woman  presented at our observa-
tion for breast cancer surgical treatment. She had her breast cancer
diagnosis after a screening mammographic examination.
Mammography showed typical features of breast cancer while
ultrasonography did not show any typical pattern of neopla-
sia. Irregular calciﬁcations were detected by mammographic
examination in three breast quadrants: infero-central (18 mm),
middle-outer (19 mm)  and supero-central (8 mm)  (Figs. 1–3).A stereotactic biopsy was  performed at the level of the three
mammographic suspected areas. Histological ﬁndings demon-
strated the evidence of malignancy in all the mentioned areas (B5,
low grade ductal carcinoma in situ).
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wFig. 2. Mammography shows the middle-outer micro-calciﬁcations. (a: cranio
Patient’s general conditions were good and no systemic patholo-
ies were noted.
Breast volume was considered adequate to perform breast con-
erving surgery (BCS). Physical examination did not reveal any
alpable lesion; axillary lymphadenopathy and skin inﬁltration
ere not observed.
In order to perform BCS we localized the three lesions using
c99-MAA (Technetium 99 m Albumin Aggregated); the sentinel
ymph node was localized pre-operatively injecting Tc99m-
anocoll.
We performed three radio-guided cancer resections with
ide margins (more than 10 mm).  All specimens were sent foral projection, b: medio-lateral projection, c: cranio-caudal magniﬁcation detail)
radiographic examination showing the radicality of the excision
(Figs. 4–6).
A therapeutic inferior pedicle mammaplasty was  performed
achieving radical resection of the three clusters of microcalciﬁca-
tions.
Then we  performed sentinel lymph-node biopsy (SNLB) that
was found to be negative for metastasis at intra-operatory frozen
section and ﬁnally we  approached the breast reshaping and the
contralateral breast symmetrization with a reduction mastoplasty
with a supero-medial pedicle (Fig. 7).
The deﬁnitive histopathological examination revealed for all the




























Fig. 3. Mammography shows the supero-central micro-calciﬁcations. (a: cranio-caudal projection, b: medio-lateral projection, c: oblique magniﬁcation detail)
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pig. 4. Radiographic examination showing the radicality of the infero-central
umpectomy.
One day after surgery we discharged the patient who  showed
linical stability and a pleasant aesthetic result at 1 month (Fig. 8).
. Discussion
The conserving surgical approach represents over 70% of breast
ancer surgical treatment in many European countries; breast sur-
eons should consider breast conserving surgery as the treatment
f choice when technically feasible and oncologically safe [12–15].
BCS followed by radiotherapy presents outcomes and over-
ll survival comparable with patients treated with mastectomy
16–20].
In cases requiring large excisions, the oncoplastic techniques
epresent the only way  to avoid major deformities of the breast.
lough et. al developed a suitable oncoplastic atlas offering a quad-
ant per quadrant solution [7].
OPBS leads to better cosmetic results if compared with standard
onserving approaches and the immediate positive psychological
mpact on the patient is evident.Moreover some authors presented better results in terms of
uality of life with breast conservation when compared with
astectomy, reconstruction and radiation therapy, because the
atients have a better-perceived body image [21].Fig. 5. Radiographic examination showing the radicality of the middle-outer
lumpectomy.
Positive margins seem to be less frequent following oncoplastic
breast surgery when compared with traditional BCS [22–24].
However, we do not have long-term data on oncological out-
come of so-called “extreme oncoplastic surgery”.
Breast conserving therapy bases its rationale on the historical
randomized controlled trials of the 1970s [16–20], where the max-
imum allowed tumor size was  5 cm,  so we do not have level I
evidences about breast preservation in patients with tumors larger
than 5 cm.
Nowadays the use of oncoplastic techniques allows the com-
plete excision of tumors even larger than 5 cm with an accetable
aesthetic result. Moreover the standard for adequate surgical mar-
gins is nowadays no ink on tumor [25], so the probability of an
oncologically safe procedure increases.
Post-mastectomy radiation therapy (PMRT) could increase the
complication rate of implant-based breast reconstruction. Timing
of reconstruction in relation of the radiation therapy timing still
remains issue of debate [26].
Autologous ﬂap reconstructions could improve outcomes in
radiotreated patients, but not all patients would like to undergo
complex and longer interventions with possible signiﬁcant mor-
bidity and a longer hospital stay.
Furthermore avoiding the use of breast implants allows an infe-
rior number of surgical interventions with obvious economical
implications.
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Fig. 7. The patient was marked for a standard reduction with three lumpectomies
and contralateral symmetrization reduction. Pre-operative planning of the inverted-
T  mastoplasty.
Sources of fundingumpectomy.
Multifocal (MF) and multicentric (MC) breast cancers are known
o be more aggressive if compared with unifocal disease. In fact the
iological patterns of malignancy (age, grade, HER-2 status, hor-
one receptor status, lymphovascular invasion) seem to be more
ggressive in this group of patients such as the lymph node status
27–29].
The surgical treatment for MF  and MC  cancers remains contro-
ersial [30,31]. Lynch et al. presented data about MC  and MF  breast
ancers treated by BCS, showing no statistically signiﬁcant differ-
nces in term of local recurrence when compared with patients
reated with mastectomy [32]. Currently the management of this
ind of cancers changed considerably: BCS is considered now a
orth alternative to mastectomy [32–34]. A recent paper by Shaikh
t al. conﬁrms that MF  and MC  breast cancers local recurrence rates
re not related to the primary surgical approach [35].Fig. 8. One-month post-operative results.
We  are sure that MF  and MC breast cancer need a mul-
tidisciplinary approach, but in our opinion oncoplastic breast
conserving surgery could be considered a safe surgical approach
for selected patients, even though randomized controlled trials on
larger cohorts should be auspicable in order to obtain higher levels
of evidence about the use of oncoplastic breast conserving surgery
in multicentric breast cancer.
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